DE60123528D1 - Verwendung eines Mittels zur Verbesserung der Astrozytenfunktion zur Behandlung von Parkinsons Krankheit - Google Patents

Verwendung eines Mittels zur Verbesserung der Astrozytenfunktion zur Behandlung von Parkinsons Krankheit

Info

Publication number
DE60123528D1
DE60123528D1 DE60123528T DE60123528T DE60123528D1 DE 60123528 D1 DE60123528 D1 DE 60123528D1 DE 60123528 T DE60123528 T DE 60123528T DE 60123528 T DE60123528 T DE 60123528T DE 60123528 D1 DE60123528 D1 DE 60123528D1
Authority
DE
Germany
Prior art keywords
parkinson
agent
disease
treatment
astrocyte function
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60123528T
Other languages
English (en)
Other versions
DE60123528T2 (de
Inventor
Yasuto Itoyama
Hiroyuki Kato
Tsutomu Araki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ono Pharmaceutical Co Ltd
Original Assignee
Ono Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co Ltd filed Critical Ono Pharmaceutical Co Ltd
Publication of DE60123528D1 publication Critical patent/DE60123528D1/de
Application granted granted Critical
Publication of DE60123528T2 publication Critical patent/DE60123528T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
DE60123528T 2000-07-18 2001-07-17 Verwendung eines Mittels zur Verbesserung der Astrozytenfunktion zur Behandlung von Parkinsons Krankheit Expired - Lifetime DE60123528T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000216763 2000-07-18
JP2000216763 2000-07-18

Publications (2)

Publication Number Publication Date
DE60123528D1 true DE60123528D1 (de) 2006-11-16
DE60123528T2 DE60123528T2 (de) 2007-02-15

Family

ID=18711968

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60123528T Expired - Lifetime DE60123528T2 (de) 2000-07-18 2001-07-17 Verwendung eines Mittels zur Verbesserung der Astrozytenfunktion zur Behandlung von Parkinsons Krankheit

Country Status (19)

Country Link
US (2) US7019032B2 (de)
EP (1) EP1174131B1 (de)
KR (1) KR100759771B1 (de)
CN (1) CN1179722C (de)
AT (1) ATE341318T1 (de)
AU (1) AU780328B2 (de)
BR (1) BR0102940A (de)
CA (1) CA2353205C (de)
DE (1) DE60123528T2 (de)
DK (1) DK1174131T3 (de)
ES (1) ES2272383T3 (de)
HU (1) HUP0102987A3 (de)
MX (1) MXPA01007210A (de)
NO (1) NO20013544L (de)
NZ (1) NZ513040A (de)
PT (1) PT1174131E (de)
RU (1) RU2275906C2 (de)
TW (1) TWI290831B (de)
ZA (1) ZA200105886B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100759771B1 (ko) * 2000-07-18 2007-10-04 오노 야꾸힝 고교 가부시키가이샤 성상세포 기능 개선제를 유효 성분으로 함유하는 파킨슨병치료제
US7928143B2 (en) 2003-10-03 2011-04-19 Ono Pharmaceutical Co., Ltd. Method for preventing and/or treating neurodegenerative diseases
WO2005032537A1 (en) * 2003-10-03 2005-04-14 Ono Pharmaceutical Co., Ltd. Method for preventing and/or treating neurodegenerative diseases
BRPI0415001A (pt) * 2003-10-03 2006-11-07 Ono Pharmaceutical Co droga contendo ácido (2r)-2-propiloctanóico como o ingrediente ativo
US20070066686A1 (en) * 2003-10-03 2007-03-22 Ono Pharmaceutical Co., Ltd. Infusion preparation containing (2r)-2-propyloctanoic acid as at the active ingredient
JP4730303B2 (ja) 2004-04-28 2011-07-20 小野薬品工業株式会社 （２ｒ）−２−プロピルオクタン酸とアミンとからなる結晶
TW200613009A (en) * 2004-06-11 2006-05-01 Ono Pharmaceutical Co Capsule having chewing stability
EP1997486B1 (de) 2006-03-09 2012-05-16 Ono Pharmaceutical Co., Ltd. Therapeutisches mittel für funktionale gehirnerkrankungen
US20110112010A1 (en) * 2008-02-15 2011-05-12 The Government of the United States of America, as represented by The National Institutes of Health Octanoic acid formulations and methods of treatment using the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU209564B (en) 1991-01-30 1994-07-28 Egyt Gyogyszervegyeszeti Gyar Process for producing rapide tablets containing levodopa and carbidopa
EP0632008B1 (de) * 1993-06-01 1998-02-04 Ono Pharmaceutical Co., Ltd. Pentansäurederivate
US5672746A (en) 1994-08-30 1997-09-30 American Biogenetic Sciences, Inc. Antiproliferative and neurotrophic molecules
KR100759771B1 (ko) * 2000-07-18 2007-10-04 오노 야꾸힝 고교 가부시키가이샤 성상세포 기능 개선제를 유효 성분으로 함유하는 파킨슨병치료제

Also Published As

Publication number Publication date
ES2272383T3 (es) 2007-05-01
CA2353205A1 (en) 2002-01-18
EP1174131A1 (de) 2002-01-23
EP1174131B1 (de) 2006-10-04
ZA200105886B (en) 2002-01-17
TWI290831B (en) 2007-12-11
MXPA01007210A (es) 2004-10-29
NZ513040A (en) 2003-02-28
AU5446401A (en) 2002-01-24
PT1174131E (pt) 2007-01-31
HU0102987D0 (en) 2001-09-28
BR0102940A (pt) 2002-03-05
US20060052453A1 (en) 2006-03-09
NO20013544L (no) 2002-01-21
NO20013544D0 (no) 2001-07-17
HUP0102987A3 (en) 2003-02-28
CN1179722C (zh) 2004-12-15
KR100759771B1 (ko) 2007-10-04
CN1334081A (zh) 2002-02-06
KR20020007188A (ko) 2002-01-26
DK1174131T3 (da) 2007-02-05
DE60123528T2 (de) 2007-02-15
RU2275906C2 (ru) 2006-05-10
US7019032B2 (en) 2006-03-28
US20020032185A1 (en) 2002-03-14
HUP0102987A2 (hu) 2002-04-29
AU780328B2 (en) 2005-03-17
CA2353205C (en) 2008-10-07
ATE341318T1 (de) 2006-10-15

Similar Documents

Publication Publication Date Title
ATE396174T1 (de) Hydroxyalkylaminderivate als beta-secretase- inhibitoren und deren verwendung zur behandlung der alzheimerschen krankheit oder ähnlicher krankheiten
CY1111951T1 (el) Φαινυλο-καρβοξαμιδικες ενωσεις χρησιμες για την αντιμετωπιση πονου
DE60316779D1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
DE60312736D1 (de) 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems
ATE184483T1 (de) Spirooxathiolan-quinuclidin-derivat zur behandlung des sjögren-syndroms
DE60123528D1 (de) Verwendung eines Mittels zur Verbesserung der Astrozytenfunktion zur Behandlung von Parkinsons Krankheit
DE3888340T2 (de) Verwendung von 1,4-disubstituierten-Piperidinyl-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung von Schlaflosigkeit.
DE60035429D1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
SE0102147D0 (sv) New methods
DE69929362D1 (de) verwendung von 1,4-benzothiazepinen zur Herstellung eines Medikaments ZUR BEHANDLUNG DER VORHOF-FIBRILLATION
DE60239165D1 (de) Perkutane absorptionszubereitungen mit 3-methyl-1-phenyl-2-pyrazolin-5-on
DE602004019778D1 (de) Verwendung von 2-amino-1,3-propandiolderivaten zur herstellung eines medikaments zur behandlung von bestimmten schmerzen
CA2534634A1 (en) Azolidinecarbonitriles and their use as dpp-iv inhibitors
ATE175350T1 (de) Zusammensetzung zur vorbeugung und behandlung von myopie
DE60104589D1 (de) Therapeutisches Mittel zur Behandlung von Dermatitis
ATE235900T1 (de) Hemmer der subepithelialen turbidität
DE60143671D1 (de) Behandlung von neuropathischen schmerzen mittels eines n-methyl-d-aspartate (nmda)-rezeptor-antagonists
ATE382367T1 (de) Behandlung des typ 1 diabetes vor und nach expression von prädispositionsmarkern
ATE212842T1 (de) Quinoxalin-derivate zur behandlung von tinnitus
ATE283269T1 (de) 5-(heteroaryl)alkyl)-3-oxo-pyrido(1,2- a)benzimidazol-4-carboxamid (pbi) derivate zur behandlung von störungen des zentralen nervensystems
DE69532963D1 (de) Verwendung von 4-acylaminopyridin derivaten zur Herstellung eines Medikaments für die Behandlung von zerebrovaskulären Erkrankungen
ATE175351T1 (de) Therapeutisches mittel zur behandlung von ischämischen oder reperfusion schädigungen des myokards
DE60034580D1 (de) Peptid zur behandlung von nervenerkrankungen
ATE81465T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
ATE199318T1 (de) Dopaminreinkorporationshemmer zur behandlung des parkinsonschen syndroms

Legal Events

Date Code Title Description
8364 No opposition during term of opposition